Franco Mastroianni

Head Department

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Franco Mastroianni is the Head of the Department at F. Miulli General Hospital in Italy. His research primarily focuses on the impact of various treatments in COVID-19 patients, including studies on hydroxychloroquine, heparin, and oral anticoagulant drugs. He has also contributed to understanding cardiovascular risk factors and complications arising in COVID-19 patients, as well as factors associated with delirium in older patients. Through his recent publications, he aims to enhance clinical outcomes in infectious diseases and geriatric medicine.

Articles (8)

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Rossella Marcucci

associate professore

University of Florence

ITALY

View details

Gianluca ISAIA

Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino

ITALY

View details

Lorenzo Blandi

University of Pavia

ITALY

View details

Fabiana Tezza

ITALY

View details

francesco cacciatore

Professor Internal Medicine

University of Naples Federico II

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Franco Mastroianni

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering

Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study

Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia.

Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Collaborators (5)

Rossella Marcucci

Gianluca ISAIA

Lorenzo Blandi

Fabiana Tezza

francesco cacciatore

Make your next move.